Home » Topics » Conferences

Conferences
RSS

E-5531: a synthetic endotoxin antagonist developed at Eisai

Dec. 11, 1997

Novel antithrombotic agent developed at Otsuka

Dec. 11, 1997

Ono-4007: antitumor lipid A analogue that enhances TNF production by macrophages

Dec. 10, 1997

Preclinical toxicity profile of ISIS-2503

Dec. 9, 1997

Safe and effective new D2 partial agonist in development at Wyeth-Ayerst

Dec. 9, 1997

AMPA antagonist investigated for treatment of drug withdrawal

Dec. 9, 1997

Novel valproic acid prodrug reported at scientific meeting

Dec. 9, 1997

New antihyperalgesic agents from Adolor

Dec. 9, 1997

Pfizer improves on NMDA antagonists

Dec. 9, 1997

New muscarinic compound from Wyeth-Ayerst

Dec. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026